With Actos ads, Takeda looks to distance drug from Avandia
November 16 2007
Days after FDA ordered a second black-box warning for GlaxoSmithKline's controversial diabetes drug Avandia, Takeda is looking to capitalize on ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.